Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cincinnati Financial Corporation (CINF) vs CVS Health Corp (CVS) Price & Performance

Cincinnati Financial CorporationTrade
CVS Health CorpTrade

Price performance (Past 24H)

Key statistics

Cincinnati Financial Corporation vs CVS Health Corp — how do they compare? Cincinnati Financial Corporation trades at $173.45 (market cap $26.68B), while CVS Health Corp trades at $93.55 (market cap $122.36B). The key difference: CVS Health Corp is far larger — about 4.6× Cincinnati Financial Corporation's market cap, and CVS Health Corp pays the higher dividend (2.78%). Which is the better fit depends on your goals.

CINFCVS
Market Cap
$26.68B$122.36B
Sector
FinancialsHealth
52-Week High
$192.03$110.60
52-Week Low
$149.79$64.88
Enterprise Value
$25.80B$184.71B
Dividend Yield
2.16%2.78%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cincinnati Financial Corporation

Cincinnati Financial (CINF) trades at $176.86, down 1.22% on the day, with a bearish technical signal but strong fundamentals including a P/E of 8.35 and ROE of 21.48%. Recent Q2 2026 earnings missed estimates at $1.43 per share versus $1.84 expected, though revenue grew year-over-year. The company maintains robust cash flow, with 2025 operating cash flow at $3.11 billion, and a consistent dividend history, including a recent $0.94 payout.

Outlook is mixed: valuation appears attractive with analyst consensus price target of $195, but near-term headwinds include catastrophe losses and commercial lines weakness. Long-term growth is supported by premium expansion and investment income, though investors face risks from underwriting volatility and economic sensitivity.

CVS Health Corp

CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.

The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

Read more on CINF

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS